Metraipolis › archive › dc_c6dd5bb18d79

PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease — Europe PMC PMID:41517382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41517382
DOI
10.3390/jcm15010133
License (as archived)
solo-consultazione
Archived
2026-11-07T10:45:18.664Z
SHA-256 of the archived text
b88153b0aaecabd8c9f8511d5f0c43fceae5ea037eca734619095b54db5cb9ce
Stable URL of this page
https://metraipolis.com/documento/dc_c6dd5bb18d79

How to cite

PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease — Europe PMC PMID:41517382 — Europe PMC (en), https://europepmc.org/article/MED/41517382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6dd5bb18d79 (Metraipolis archive dc_c6dd5bb18d79, sha256 b88153b0aaecabd8c9f8511d5f0c43fceae5ea037eca734619095b54db5cb9ce)
BibTeX
@misc{dcc6dd5bb18d79,
  title = {PTH Analog Therapy in CKD G4-G5D: Current Evidence and Potential Role of Abaloparatide in Adynamic Bone Disease — Europe PMC PMID:41517382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41517382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6dd5bb18d79; sha256 b88153b0aaecabd8c9f8511d5f0c43fceae5ea037eca734619095b54db5cb9ce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41517382. Agents can read the archived copy with the MCP tool read_document.